136 related articles for article (PubMed ID: 20583995)
21. Molecular modeling of potential new and selective PET radiotracers for the serotonin transporter. Positron Emission Tomography.
Wellsow J; Kovar KA; Machulla HJ
J Pharm Pharm Sci; 2002; 5(3):245-57. PubMed ID: 12553893
[TBL] [Abstract][Full Text] [Related]
22. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.
Huang Y; Bae SA; Zhu Z; Guo N; Roth BL; Laruelle M
J Med Chem; 2005 Apr; 48(7):2559-70. PubMed ID: 15801845
[TBL] [Abstract][Full Text] [Related]
23. Radiotracers for imaging of Parkinson's disease.
Abbasi Gharibkandi N; Hosseinimehr SJ
Eur J Med Chem; 2019 Mar; 166():75-89. PubMed ID: 30685535
[TBL] [Abstract][Full Text] [Related]
24. Positron emission tomography: imaging and quantification of neurotransporter availability.
Laruelle M; Slifstein M; Huang Y
Methods; 2002 Jul; 27(3):287-99. PubMed ID: 12183117
[TBL] [Abstract][Full Text] [Related]
25. Neither cortisol nor brain-derived neurotrophic factor is associated with serotonin transporter in bipolar disorder.
Chou YH; Lirng JF; Hsieh WC; Chiu YC; Tu YA; Wang SJ
Eur Neuropsychopharmacol; 2016 Feb; 26(2):280-287. PubMed ID: 26706694
[TBL] [Abstract][Full Text] [Related]
26. PET and SPECT Tracers for Myocardial Perfusion Imaging.
Klein R; Celiker-Guler E; Rotstein BH; deKemp RA
Semin Nucl Med; 2020 May; 50(3):208-218. PubMed ID: 32284107
[TBL] [Abstract][Full Text] [Related]
27. A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylphenylamine ([11C]AFM).
Huang Y; Hwang DR; Bae SA; Sudo Y; Guo N; Zhu Z; Narendran R; Laruelle M
Nucl Med Biol; 2004 Jul; 31(5):543-56. PubMed ID: 15219271
[TBL] [Abstract][Full Text] [Related]
28. Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB.
McCann UD; Szabo Z; Seckin E; Rosenblatt P; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA
Neuropsychopharmacology; 2005 Sep; 30(9):1741-50. PubMed ID: 15841106
[TBL] [Abstract][Full Text] [Related]
29. Positron emission tomography imaging of the serotonin transporter in the pig brain using [11C](+)-McN5652 and S-([18F]fluoromethyl)-(+)-McN5652.
Brust P; Zessin J; Kuwabara H; Pawelke B; Kretzschmar M; Hinz R; Bergman J; Eskola O; Solin O; Steinbach J; Johannsen B
Synapse; 2003 Feb; 47(2):143-51. PubMed ID: 12454952
[TBL] [Abstract][Full Text] [Related]
30. Association of thalamic serotonin transporter and interleukin-10 in bipolar I disorder: a SPECT study.
Hsu JW; Lirng JF; Wang SJ; Lin CL; Yang KC; Liao MH; Chou YH
Bipolar Disord; 2014 May; 16(3):241-8. PubMed ID: 24372850
[TBL] [Abstract][Full Text] [Related]
31. Characterization of [(123)I]IDAM as a novel single-photon emission tomography tracer for serotonin transporters.
Kung MP; Hou C; Oya S; Mu M; Acton PD; Kung HF
Eur J Nucl Med; 1999 Aug; 26(8):844-53. PubMed ID: 10436197
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of carbon-11-labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-iodoethenyl)phenyl]nortropane as a potential radioligand for imaging the serotonin transporter by PET.
Plisson C; Jarkas N; McConathy J; Voll RJ; Votaw J; Williams L; Howell LL; Kilts CD; Goodman MM
J Med Chem; 2006 Feb; 49(3):942-6. PubMed ID: 16451060
[TBL] [Abstract][Full Text] [Related]
33. Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET.
Vanicek T; Kutzelnigg A; Philippe C; Sigurdardottir HL; James GM; Hahn A; Kranz GS; Höflich A; Kautzky A; Traub-Weidinger T; Hacker M; Wadsak W; Mitterhauser M; Kasper S; Lanzenberger R
Hum Brain Mapp; 2017 Feb; 38(2):792-802. PubMed ID: 27770470
[TBL] [Abstract][Full Text] [Related]
34. Is correction for age necessary in SPECT or PET of the central serotonin transporter in young, healthy adults?
Buchert R; Schulze O; Wilke F; Berding G; Thomasius R; Petersen K; Brenner W; Clausen M
J Nucl Med; 2006 Jan; 47(1):38-42. PubMed ID: 16391185
[TBL] [Abstract][Full Text] [Related]
35. Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects.
Reneman L; de Win MM; van den Brink W; Booij J; den Heeten GJ
J Psychopharmacol; 2006 Mar; 20(2):164-75. PubMed ID: 16510475
[TBL] [Abstract][Full Text] [Related]
36. Binding kinetics of 123I[ADAM] in healthy controls: a selective SERT radioligand.
Sacher J; Asenbaum S; Klein N; Geiss-Granadia T; Mossaheb N; Poetzi C; Attarbaschi T; Lanzenberger R; Spindelegger C; Rabas A; Heinze G; Dudczak R; Kasper S; Tauscher J
Int J Neuropsychopharmacol; 2007 Apr; 10(2):211-8. PubMed ID: 16487452
[TBL] [Abstract][Full Text] [Related]
37. In Vivo Evaluation of 11C-DASB for Quantitative SERT Imaging in Rats and Mice.
Walker M; Ehrlichmann W; Stahlschmidt A; Pichler BJ; Fischer K
J Nucl Med; 2016 Jan; 57(1):115-21. PubMed ID: 26514178
[TBL] [Abstract][Full Text] [Related]
38. Serotonin transporter availability may moderate the association between perceiving stress and depressive tendencies - A SPECT with 5-HTTLPR genotyping study.
Lin SH; Lee IH; Chen KC; Chen PS; Chiu NT; Yao WJ; Yang YK
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Aug; 61():24-9. PubMed ID: 25816791
[TBL] [Abstract][Full Text] [Related]
39. Decreased brain serotonin transporter binding in the euthymic state of bipolar I but not bipolar II disorder: a SPECT study.
Chou YH; Wang SJ; Lin CL; Mao WC; Lee SM; Liao MH
Bipolar Disord; 2010 May; 12(3):312-8. PubMed ID: 20565438
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
